GAMP 5 is ISPE's risk-based guide to validating GxP computerized systems. This guide explains software categories 1, 3, 4 and 5, what the July 2022 second edition changed, whether GAMP 5 is required, what 21 CFR 211.68 asks of computerized systems, and how each category maps to the 183 citations FDA investigators wrote under 211.68 at 774 Part 211 drug inspections closed January 2025 to October 2026.